Boosting with an adenovirus-based vaccine improves protective efficacy against Venezuelan equine encephalitis virus following DNA vaccination

Vaccine

Volumn 24, Issue 17, 2006, Pages 3440-3445

  Perkins, Stuart D ^a   O'Brien, Lyn M ^a   Phillpotts, Robert J ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

Adenovirus; DNA vaccine; Prime boost; VEEV; Venezuelan equine encephalitis virus

Indexed keywords

DNA VACCINE; GLYCOPROTEIN E2; IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARBOVIRUS; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIRUS NEUTRALIZATION;

ADENOVIRIDAE; ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIBODIES, VIRAL; ENCEPHALITIS VIRUS, VENEZUELAN EQUINE; FEMALE; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; VACCINES, DNA; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 33645236905     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.02.020     Document Type: Article

References (39)

1. D.L. Woodland Jump-starting the immune system: prime-boosting comes of age Trends Immunol 25 2 2004 98 104
2. R.R. Amara, F. Villinger, and J.D. Altman Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine Science 292 5514 2001 69 74
3. J.W. Shiver, T.M. Fu, and L. Chen Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity Nature 415 6869 2002 331 335
4. S.J. Kent, A. Zhao, S.J. Best, J.D. Chandler, D.B. Boyle, and I.A. Ramshaw Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus J Virol 72 12 1998 10180 10188
5. S.J. McConkey, W.H. Reece, and V.S. Moorthy Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans Nat Med 9 6 2003 729 735
6. A.C. Moore, and A.V. Hill Progress in DNA-based heterologous prime-boost immunization strategies for malaria Immunol Rev 199 2004 126 143
7. S.C. Weaver, C. Ferro, R. Barrera, J. Boshell, and J.C. Navarro Venezuelan equine encephalitis Annu Rev Entomol 49 2004 141 174
8. W.H.J. Dietz, P.H. Peralta, and K.M. Johnson Ten clinical cases of human infection with Venezuelan equine encephalomyelitis virus, subtype I-D Am J Trop Med Hyg 28 1979 329 334
9. J. de Mucha-Macias, and I. Sanchez-Spindola Two human cases of laboratory infection with Mucambo virus Am J Trop Med Hyg 14 1965 475 478
10. W.F. Klietmann, and K.L. Ruoff Bioterrorism: implications for the clinical microbiologist Clin Microbiol Rev 14 2 2001 364 381
11. R.J. Hawley, and E.M. Eitzen Jr. Biological weapons - a primer for microbiologists Annu Rev Microbiol 55 2001 235 253
12. M.R. Hilleman Overview: cause and prevention in biowarfare and bioterrorism Vaccine 20 25-26 2002 3055 3067
13. K. Alibek The emerging BW threat: lessons from the Russian Offensive BW R&D program, 1945 to 1992 1999 Maxwell AFB Alabama
14. Stockholm International Peace Research Institute The problem of chemical and biological warfare. Volume 2. CB weapons today 1973 Almqvist and Wiksell Stockholm
15. K.M. Johnson, and D.H. Martin Venezuelan equine encephalitis Adv Vet Sci Comp Med 18 1974 79 116
16. R.W. Titball, and E.D. Williamson Vaccine development for potential bioterrorism agents Curr Drug Targets Infect Disord 3 3 2003 255 262
17. W.D. Pratt, N.L. Davis, R.E. Johnston, and J.F. Smith Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models Vaccine 21 25-26 2003 3854 3862
18. A.M. Bennett, R.J. Phillpotts, S.D. Perkins, S.C. Jacobs, and E.D. Williamson Gene gun mediated vaccination is superior to manual delivery for immunisation with DNA vaccines expressing protective antigens from Yersinia pestis or Venezuelan equine encephalitis virus Vaccine 18 7-8 1999 588 596
19. J. Riemenschneider, A. Garrison, and J. Geisbert Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus. Marburg virus and Venezuelan equine encephalitis virus Vaccine 21 25-26 2003 4071 4080
20. R.J. Phillpotts, L. O'Brien, R.E. Appleton, S. Carr, and A. Bennett Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus Vaccine 23 13 2005 1615 1623
21. S.J. Elvin, A.M. Bennett, and R.J. Phillpotts Role for mucosal immune responses and cell-mediated immune functions in protection from airborne challenge with Venezuelan equine encephalitis virus J Med Virol 67 3 2002 384 393
22. R.J. Phillpotts, T.J. Brooks, and C.S. Cox A simple device for the exposure of animals to infectious microorganisms by the airborne route Epidemiol Infect 118 1 1997 71 75
23. A.C. Guyton Measurement of the respiratory volume of laboratory animals Am J Physiol 150 1947 70 77
24. A.J. Wright, and R.J. Phillpotts Humane endpoints are an objective measure of morbidity in Venezuelan encephalomyelitis virus infection of mice Arch Virol 143 6 1998 1155 1162
25. L. Leung, I.K. Srivastava, and E. Kan Immunogenicity of HIV-1 Env and Gag in baboons using a DNA prime/protein boost regimen Aids 18 7 2004 991 1001
26. A. Habel, C. Chanel, and R. Le Grand DNA vaccine protection against challenge with simian/human immunodeficiency virus 89.6 in Rhesus macaques Dev Biol (Basel) 104 2000 101 105
27. C. Coban, M.T. Philipp, and J.E. Purcell Induction of Plasmodium falciparum transmission-blocking antibodies in nonhuman primates by a combination of DNA and protein immunizations Infect Immun 72 1 2004 253 259
28. M. Mincheff, S. Tchakarov, and S. Zoubak Naked DNA and adenoviral immunizations for immunotherapy of prostate cancer: a phase I/II clinical trial Eur Urol 38 2 2000 208 217
29. T. Hanke, A.J. McMichael, and R.V. Samuel Lack of toxicity and persistence in the mouse associated with administration of candidate DNA- and modified vaccinia virus Ankara (MVA)-based HIV vaccines for Kenya Vaccine 21 1-2 2002 108 114
30. A.M. Bennett, S.J. Elvin, A.J. Wright, S.M. Jones, and R.J. Phillpotts An immunological profile of Balb/c mice protected from airborne challenge following vaccination with a live attenuated Venezuelan equine encephalitis virus vaccine Vaccine 19 2-3 2000 337 347
31. P.B. Jahrling, and E.H. Stephenson Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters J Clin Microbiol 19 3 1984 429 431
32. R.J. Phillpotts, and A. Wright TC-83 vaccine protects against airborne or subcutaneous challenge with heterologous mouse-virulent strains of Venezuelan equine encephalitis virus Vaccine 17 1999 982 988
33. M.K. Hart, W. Pratt, F. Panelo, R. Tammariello, and M. Dertzbaugh Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice Vaccine 15 4 1997 363 369
34. R.J. Phillpotts, L.D. Jones, and S.C. Howard Monoclonal antibody protects mice against infection and disease when given either before or up to 24 h after airborne challenge with virulent Venezuelan equine encephalitis virus Vaccine 20 2002 1497 1504
35. J.H. Mathews, J.T. Roehrig, and D.W. Trent Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies J Virol 55 3 1985 594 600
36. L.D. Jones, A.M. Bennett, S.R. Moss, E.A. Gould, R.J. Phillpotts, and Cytotoxic T-cell activity is not detectable in Venezuelan equine encephalitis virus-infected mice Virus Res 91 2 2003 255 259
37. M. Matsui, O. Moriya, and T. Akatsuka Enhanced induction of hepatitis C virus-specific cytotoxic T lymphocytes and protective efficacy in mice by DNA vaccination followed by adenovirus boosting in combination with the interleukin-12 expression plasmid Vaccine 21 15 2003 1629 1639
38. N.J. Sullivan, T.W. Geisbert, and J.B. Geisbert Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates Nature 424 6949 2003 681 684
39. H.J. Dean, J. Haynes, and C. Schmaljohn The role of particle-mediated DNA vaccines in biodefense preparedness Adv Drug Deliv Rev 57 9 2005 1315 1342